Altium Wealth Management LLC Genmab A/S Transaction History

Altium Wealth Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$35.87 - $47.12 $227,344 - $298,646	-6,338 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $68,806 - $80,680	-1,656 Reduced 20.72%	6,338 $277,000
Q2 2021 Aug 13, 2021	BUY	$32.88 - $44.57 $25,087 - $34,006	763 Added 10.55%	7,994 $326,000
Q1 2021 May 06, 2021	SELL	$30.92 - $44.4 $22,200 - $31,879	-718 Reduced 9.03%	7,231 $237,000
Q4 2020 Feb 04, 2021	BUY	$33.66 - $40.76 $267,563 - $324,001	7,949 New	7,949 $323,000

241

47.6M

31.3K

38.7K

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $16.8B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

Get notified when there are updates to the investment portfolio of Altium Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Altium Wealth Management LLC with notifications on news.